who is a good candidate for glp-1 Semaglutide vs Tirzepatide: Which Right You? – Calibrate IV Are you a good candidate

Therefore, particularly for these drugs, frequent updates are essential to accurately assess the drugs long-term benefits

Our experience across peptide research protocols shows that the 'which is better' question only makes sense once you've defined what outcome you're measuring

Drug interactions are most clinically important with insulin and sulfonylureas (hypoglycaemia risk), DPP-4 inhibitors (dont combine), and (for Mounjaro only) oral contraceptives and oral HRT

Even though none of these theories have been mechanistically proven during a hypoglycemic event, an increase in GLP-1 could be associated with hepatic autophagy

Longitudinal titration needs: Repeated dose decisions are expected to favor platforms built for continuing care